Drug Design, Development and Therapy

Drug Design, Development and Therapy is an open access peer-reviewed medical journal covering research on drug design and development through to clinical applications. The journal was established in 2007 and is published by Dove Medical Press.^[1]

Drug Design, Development and Therapy

Discipline	Drug development
Language	English
Edited by	Professor Frank Boekler
Publication details
History	2007–present
Publisher	Dove Medical Press
Open access	Yes
Impact factor	5.1 (2024)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Drug Des. Dev. Ther.
NLM	Drug Des Devel Ther
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L
ISSN	1177-8881
OCLC no.	502420997
Links
Journal homepage Online Access - Volume 19 (2025)

The journal covers research on drug design and development through to clinical applications, serving pharmaceutical chemists, clinicians, and principal investigators in both academic and industrial settings. They publish application notes, reviews, original research articles, and clinical studies across therapeutic areas, with emphasis on drug discovery, molecular and computer-aided design, biologically active compounds, biotechnology, natural products, pharmacokinetics, drug delivery, preclinical and translational studies, toxicology, advanced therapies, personalized medicine, and clinical evaluation. Particular focus is placed on clinical outcomes, patient safety, and the effective and sustained use of medicines. ^[2]

This journal subscribes to the principles of the Committee on Publication Ethics.